Clinical trial
A Randomized, Multi-Center Study of the Pimecrolimus-Eluting and…
NCT00322569 · Cordis US Corp., Industry · Completed
Key facts
| NCT number | NCT00322569 |
|---|---|
| Title | A Randomized, Multi-Center Study of the Pimecrolimus-Eluting and Pimecrolimus/Paclitaxel-Eluting Coronary Stent Systems (GENESIS) |
| Official title | A Randomized, Multi-Center Study of the Pimecrolimus-Eluting (Corio™) and Pimecrolimus/Paclitaxel-Eluting Coronary Stent System (SymBio™) in Patients With De Novo Lesions of the Native Coronary Arteries |
| Lead sponsor | Cordis US Corp., Industry |
| Collaborators | Conor Medsystems Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Coronary Disease |
| Intervention type | Device |
| Interventions | Corio™ Pimecrolimus-Eluting Coronary Stent System, SymBio™ Pimecrolimus/Paclitaxel-Eluting Coronary Stent System, Costar ™ Paclitaxel-Eluting Coronary Stent System |
| Enrollment | 246 |
| Start date | Jul 1, 2006 |
| Primary completion | Oct 1, 2007 |
| Completion | May 1, 2012 |
| First posted | May 8, 2006 |
| Last update posted | Mar 6, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: